Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of Injectable, Long-Acting Nevirapine for HIV Prophylaxis in Breastfeeding Infants
Authors
Keywords
-
Journal
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Volume 59, Issue 1, Pages 59-66
Publisher
American Society for Microbiology
Online
2014-10-14
DOI
10.1128/aac.03906-14
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Compartmental Pharmacokinetic Evaluation of Long-Acting Rilpivirine in HIV-Negative Volunteers for Pre-Exposure Prophylaxis
- (2014) A G A Jackson et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Long-acting HIV drugs advanced to overcome adherence challenge
- (2014) Elie Dolgin NATURE MEDICINE
- Long-Acting Integrase Inhibitor Protects Macaques from Intrarectal Simian/Human Immunodeficiency Virus
- (2014) C. D. Andrews et al. SCIENCE
- Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
- (2013) Nagsen Gautam et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients
- (2013) Jennifer Williams et al. Nanomedicine
- Long-acting injectable antiretrovirals for HIV treatment and prevention
- (2013) William R. Spreen et al. Current Opinion in HIV and AIDS
- Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
- (2012) Prasanta K. Dash et al. AIDS
- Population Pharmacokinetic Analysis of a Nevirapine-Based HIV-1 Prevention of Mother-to-Child Transmission Program in Uganda to Assess the Impact of Different Dosing Regimens for Newborns
- (2012) Monika Frank et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Quantifying the Impact of Nevirapine-Based Prophylaxis Strategies To Prevent Mother-to-Child Transmission of HIV-1: a Combined Pharmacokinetic, Pharmacodynamic, and Viral Dynamic Analysis To Predict Clinical Outcomes
- (2011) M. Frank et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Efficacy and safety of nevirapine extended-release once daily versus nevirapine immediate-release twice-daily in treatment-naive HIV-1-infected patients
- (2011) Joseph Gathe et al. ANTIVIRAL THERAPY
- Bioavailability of nevirapine in rats after oral and subcutaneous administration, in vivo absorption from gastrointestinal segments and effect of bile on its absorption from duodenum
- (2011) Iris Usach et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Surface modified nevirapine nanosuspensions for viral reservoir targeting: In vitro and in vivo evaluation
- (2011) Ranjita Shegokar et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- To scale or not to scale: the principles of dose extrapolation
- (2009) Vijay Sharma et al. BRITISH JOURNAL OF PHARMACOLOGY
- New approaches for quantitating the inhibition of HIV-1 replication by antiviral drugs in vitro and in vivo
- (2009) Moira A McMahon et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
- (2008) Lin Shen et al. NATURE MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started